Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion evidence source_evidence_literature NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion SIO_000772 23526220 NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion wasDerivedFrom befree-2016 NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion wasGeneratedBy ECO_0000203 NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.